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TET enzymes produce oxidized methylcytosines, intermediates in DNA demethylation as well as new 
epigenetic marks.  Here we show data suggesting that TET proteins maintain the consistency of gene 
transcription. Embryos lacking Tet1 and Tet3 (Tet1/3 DKO) displayed a strong loss of 5-
hydroxymethylcytosine (5hmC) and a concurrent increase in 5-methylcytosine (5mC) at the 8-cell 
stage. Single cells from 8-cell embryos and individual E3.5 blastocysts showed unexpectedly variable 
gene expression compared to controls, and this variability correlated in blastocysts with variably 
increased 5mC/5hmC in gene bodies and repetitive elements.  Despite the variability, genes encoding 
regulators of cholesterol biosynthesis were reproducibly downregulated in Tet1/3 DKO blastocysts, 
resulting in a characteristic phenotype of holoprosencephaly in the few embryos that survived to later 
stages.  Thus TET enzymes and DNA cytosine modifications could directly or indirectly modulate 
transcriptional noise, resulting in the selective susceptibility of certain intracellular pathways to 
regulation by TET proteins.   
 
 
Significance 
Development of pre-implantation embryos entails global DNA demethylation on the zygotic genome. The 
original thought was that TET-deficient embryos would be unlikely to survive early embryogenesis since they 
would be unable to mediate genome-wide demethylation in the zygote and pre-implantation embryo. However, 
mice lacking the individual TET proteins Tet1, Tet2 or Tet3 have survived until birth and beyond, suggesting 
redundancy among TET proteins in the early embryogenesis. Here we report that pre-implantation embryos 
doubly disrupted for Tet1 and Tet3 show abnormal embryonic phenotypes, whose incomplete penetrance 
correlates with a high variability of transcriptional profiles and DNA methylation status. Our data suggest that in 
addition to facilitating DNA demethylation, TET proteins and oxidized methylcytosines may regulate the 
consistency of gene transcription during embryogenesis. 
  
\body 
The three mammalian TET proteins TET1, TET2 and TET3 alter the modification status of cytosines in DNA by 
successively oxidizing 5mC to 5hmC, 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) (1-3).  All three 
oxidised methylcytosines (oxi-mC) are intermediates in DNA demethylation, the complete conversion of 5mC 
to C (reviewed in (4, 5)).  At least two mechanisms appear to be involved: inhibition of the maintenance 
methyltransferase activity of the DNMT1/UHRF1 complex (6), and excision of 5caC and 5fC by thymine DNA 
glycosylase (TDG) (3, 7, 8).  Since DNA demethylation occurs in a genome-wide fashion during embryonic 
development, there has been considerable interest in the role of TET proteins in early embryogenesis.   
Genome-wide DNA demethylation is observed at two stages of embryonic development, in the fertilized zygote 
and during the specification of primordial germ cells (PGCs) (9, 10).  In PGCs, Tet1 and Tet2 contribute to 
DNA demethylation through a replication-dependent mechanism (9).  In fertilized zygotes, Tet3 was originally 
thought to oxidize 5mC preferentially in the paternally-inherited genome (11-13); more recently, however, 
reduced-representation bisulfite sequencing (RRBS) has been used to suggest that demethylation of the 
maternal genome is also catalyzed by Tet3 (14).  RRBS measures the sum of 5mC and 5hmC (versus C, 5fC 
and 5caC) at a fraction of cytosines in the genome, and the data show that loss of 5mC+5hmC in both 
maternal and paternal pronuclei occurs primarily through a passive, replication-dependent process (14, 15).  
Despite the high expression of Tet3 in oocytes and zygotes (11), Tet3-deficient zygotes display only a marginal 
increase in 5mC+5hmC in either paternal or maternal pronuclei (14), suggesting the redundant involvement of 
other TET proteins.   
Further attesting to the redundant functions of TET-family proteins, mice lacking individual TET proteins 
develop relatively normally until birth and beyond (reviewed in (16)).  Specifically, adult Tet1 and Tet2 KO mice 
are viable and fertile, displaying relatively mild behavioral and hematopoietic phenotypes respectively (17-19), 
whereas Tet3 KO mice die perinatally for unknown reasons (11).  Tet3-deficient early embryos show no 
difference in gene expression compared to WT embryos (14), suggesting compensation from Tet1, Tet2 or 
both.  Even the double deletion of Tet1 and Tet2 has only minor consequences: a significant fraction of 
Tet1/Tet2 doubly-deficient mice survive to adulthood, while the remainder succumb late in embryogenesis or 
shortly after birth (20).  This relatively mild embryonic phenotype could reflect the potential involvement of Tet3, 
which is upregulated compared to control in embryonic stem (ES) cells, E13.5 embryos and adult brain and 
lung of Tet1/2 DKO mice (20).  Tet3 is likely to be an important player, since triple Tet1/2/3-deficient ES cells 
show significant defects in differentiation (21) and triple TET-deficient mouse embryonic fibroblasts cannot be 
reprogramed to induced pluripotent stem cells (22). Thus a complete characterization of the roles of TET 
proteins and oxi-mC modifications in early embryogenesis will require significant interference with TET 
function, through analysis of embryos deficient for Tet1/Tet3, Tet2/Tet3 or all of the three TET proteins.   
In this study, we investigated the roles of Tet1 and Tet3 in early embryonic development.  We show that single 
cells of Tet1/3 DKO 8-cell embryos display a global loss of 5hmC and gain of 5mC, indicating that Tet1 and 
Tet3 are the primary contributors to oxi-mC production at this developmental stage.  RNA sequencing of single 
blastomeres from these 8-cell embryos revealed an unexpected degree of transcriptome variability compared 
to controls, with a global effect on the majority of expressed genes irrespective of expression level.  A similar 
global variability was observed at a slightly later stage of embryonic development, by RNA-sequencing of 
single blastocysts collected at E3.5. RRBS analysis of individual blastocysts showed that the variability of gene 
transcription correlated with variably increased 5mC/5hmC in gene bodies and repetitive elements, which in 
turn correlated with pronounced phenotypic variability at both early and late stages of embryonic development. 
However, a small number of genes were reproducibly downregulated in Tet1/3 DKO blastocysts compared to 
controls; many of these encoded enzymes and transcription factors involved in lipid and cholesterol 
biosynthesis, potentially explaining a phenotype resembling holoprosencephaly observed in the few embryos 
that survived to later developmental stages (E10.5).  
 
Results  
Embryonic lethality of Tet1/3 double-deficient mice  
Consistent with previous reports (23, 24), we detected Tet1 protein at the 2-cell, 8-cell and blastocyst stages 
by immunocytochemistry, and Tet3 protein at the 2-cell but not the 8-cell stage (Fig. 1A-1C; for specificity of 
the Tet1 and Tet antisera see SI Appendix, Figs. S1D and S1E).  Thus Tet3 and Tet1 likely act in succession 
during early embryonic development, leading us to examine mice conditionally disrupted for both the Tet1 and 
the Tet3 genes (SI Appendix, Fig. S2A and S2B).  
Unlike Tet1-disrupted mice on a mixed genetic background (129Sv, C57BL/6) (17, 25), Tet1-disrupted 
C57BL/6 mice showed partial embryonic lethality – only 30% of the expected number of Tet1 KO pups 
survived to birth (SI Appendix, Fig. S3A, Table S1). Like the mixed background mice, however, C57BL/6-
background Tet1-disrupted mice were runted (SI Appendix, Fig. S3B and S3C); they showed hallmarks of 
hydrocephaly (SI Appendix, Fig. S3B), a phenomenon that may underlie some of the reported learning 
defects of the mixed background mice (17, 18); and the females were infertile with degenerated ovaries (SI 
Appendix, Fig. S3D), recalling the meiotic abnormality of Tet1 gene-trap mice (26). Tet3-disrupted mice on 
the C57BL/6 background showed perinatal lethality, as observed for 129Sv-background Tet3-/- mice (11). 
Intercrosses of Tet1+/-Tet3+/- double heterozygous parents yielded significantly smaller litters (3.4 pups/ litter) 
than those from Tet1+/- or Tet3+/- crosses (4.5 and 7.2 pups/ litter respectively), and Tet1-/-Tet3-/- pups did not 
survive to birth (SI Appendix, Fig. S3E, Table S2).  
To generate Tet1-/-Tet3-/- progeny efficiently, we bred Zp3-Cre or Stra8-Cre mice to Tet1fl/fl,Tet3fl/fl mice 
(hereafter termed Zp3DKO and Stra8DKO mice).  As control breeders, we used Tet1fl/fl, Tet3fl/fl littermates of 
the Zp3DKO females and Stra8DKO males.  None of the resulting embryos (Tet1fl/fl,Tet3fl/fl,Zp3mat,Stra8pat, 
hereafter termed Tet1/3 DKO) was viable beyond day 10.5: the majority of embryos (45/58 at day E10.5-11; 
11/15 at E12-12.5) were resorbed and the remainder showed abnormal development (SI Appendix, Fig. S3F). 
Genotyping of Tet1/3 DKO E10.5 embryos from two litters confirmed complete excision of the floxed Tet1 and 
Tet3 alleles (SI Appendix, Fig. S3G).  
Early developmental abnormalities in Tet1/3 DKO 8-cell embryos  
Focusing on early embryonic stages, we found that Tet1/3 DKO embryos showed variably delayed or aborted 
development relative to Tet1fl/fl,Tet3fl/fl (CTL) embryos: at embryonic day (E) 2.5, more than 95% of control 
embryos had reached the 8-cell stage, whereas ~25% of Tet1/3 DKO embryos were 1- and 2-cell embryos 
displaying various abnormal phenotypes including mitotic defects, apoptosis and/or nuclear blebbing or 
fragmentation (Fig. 1A and 1B). The Tet1/3 DKO embryos (~70%) that achieved the 8-cell stage by E2.5 were 
similar to control embryos, as judged by staining with antibodies to Nanog and Cdx2, lineage markers for 
primitive ectoderm and trophoectoderm respectively (Fig. 1C).  In control 8-cell embryos, 5hmC and 5mC 
occupied distinct areas of the nucleus (Fig. 1D and 1E; the distinct staining patterns of 5mC and 5hmC confirm 
good antibody specificity), but in Tet1/3 DKO 8-cell embryos, 5hmC was undetectable and instead there was 
uniform 5mC staining throughout the nucleus (Fig. 1D and 1E). Thus Tet1 and Tet3 are the major catalysts of 
5mC oxidation at early embryonic stages; in their absence, 5mC is not converted to 5hmC.    
Increased transcriptome variability in Tet1/3 DKO 8-cell blastomeres compared to controls 
To investigate how the global loss of 5hmC and increase of 5mC in Tet1/3 DKO embryos affected gene 
expression profiles at the 8-cell stage, we performed RNA-seq on single cells (blastomeres) taken from 8-cell 
DKO and control embryos, a stage at which individual blastomeres are relatively, although not completely, 
homogeneous (27, 28). We collected six 8-cell embryos from control or Tet1/3 DKO timed-matings, and 
dissociated them into two pools of 48 single blastomeres each; then randomly chose 10 control and 35 Tet1/3 
DKO single blastomeres and used them to generate single-cell RNA-seq libraries (SI Appendix, Table S3; the 
variability of the mutant phenotypes led us to collect more mutant than control blastomeres).  When single-cell 
transcriptomes of all control and Tet1/3 DKO blastomeres were analyzed with respect to spike-in controls (red 
dots), overall gene expression levels were similar between control and Tet1/3 DKO blastomeres (SI Appendix, 
Fig. S4A), but the variability of gene expression was different (Fig. 2). Unsupervised clustering distinguished 
groups A-D (Fig. 2A and SI Appendix, Fig. S4B); principal component analysis showed considerably greater 
variability in the transcriptomes of single blastomeres from Tet1/3 DKO 8-cell embryos compared to controls 
(Fig. 2A). The Group A cluster contained both control and DKO blastomeres, indicating that some Tet1/3 DKO 
blastomeres in Group A possessed relatively normal transcriptomes (Fig. 2A and SI Appendix, Fig. S4B); 
however, even in Group A, the expression of a subset of genes was different between control and Tet1/3 DKO 
single cells (SI Appendix, Fig. S4C).  Gene ontology (GO) analysis of genes differentially expressed in 
Groups B, C and D compared to Group A identified distinct categories (SI Appendix, Fig. S4D), with the GO 
terms “cell cycle” in Group C and “programmed cell death” in Group D (SI Appendix, Fig. S4D) recalling the 
abnormal phenotypes observed in 2-cell embryos (Fig. 1B) and suggesting that the same failures occur in 
some blastomeres at the 8-cell stage.  
To quantify the variability of gene expression between single blastomeres from control and Tet1/3 DKO 8-cell 
embryos we applied a variance-stabilizing transformation that normalizes variability to the level of gene 
expression (Fig. 2B-2D). The data revealed a global increase in the overall variance of gene expression in 
Tet1/3 DKO blastomeres compared to controls (Figs. 2B-D). A correlation plot for the variance of gene 
expression among the 10 control and 35 DKO blastomeres showed that essentially all genes in DKO 
blastomeres were expressed more variably than in controls (Fig. 2C; each dot represents 1 gene, and the 
majority of dots fall above the diagonal), in a manner independent of the level of gene expression (Fig. 2D). To 
test if the greater number of Tet1/3 DKO single-cells (n=35) of the blastomeres compared to the number of 
control single-cells (n=10), had an influence on the observed difference of variances, we randomly selected 10 
DKO samples and calculated gene expression variances based on the variance-stabilized data in 20 iterations. 
We observed increased variation of gene expression in all groups of 10 randomly chosen Tet1/3 DKO samples 
compared to the 10 control samples, demonstrating that the effect of increased variation is not dependent on 
the number of samples.  Zfp820 and Zbed3 were the top variable genes in single blastomeres from control and 
Tet1/3 DKO 8-cell embryos respectively, whereas Invs is an example of one of the few genes that was 
relatively stably expressed in both sets of blastomeres (Fig. 2E, SI Appendix, Fig. S4E).   
We compared our RNA-seq data for single blastomeres from 8-cell embryos with data from two previous 
reports: one study profiled gene expression by RNA-seq in zygotes and single cells from 2-cell and 4-cell 
embryos (28), whereas the second examined the expression of 48 selected genes associated with embryonic 
development in single cells from the 1-cell (zygote) until the 64-cell stage (27). Principal component analysis of 
the combined data from our study and that of Biase et al. (2014) showed that the transcriptional profiles of 
single cells from control 8-cell embryos clustered tightly into a single group distinct from 4-cell embryos, 
whereas single cells from Tet1/3 DKO 8-cell embryos showed a more variable distribution spread between the 
4-cell and 8 cell stages (Fig. 2F). Comparison with the data of Guo et al. (2010) yielded a similar result (SI 
Appendix, Fig. S4F).  
Together, these results emphasize the striking increase in the variability but not the level of gene expression in 
single blastomeres from 8-cell embryos lacking Tet1 and Tet3.  This variability was maintained at later 
embryonic stages, as discussed for E3.5 blastocysts below.   
Developmental abnormalities in Tet1/3 DKO pre-implantation and peri-implantation embryos  
We examined slightly later stages of embryonic development by immunocytochemistry (Fig. 3, SI Appendix, 
Fig. S5). All control (CTL) E3.5 pre-implantation blastocysts showed normal specification of the inner cell mass 
and trophectoderm, as judged by distinct expression of Nanog and Cdx2 (Fig. 3A, upper panel; Fig. 3B, left 
panels).  In contrast, more than 60% (10/16) of E3.5 Tet1/3 DKO embryos displayed either a severe loss of 
Nanog expression or aberrant co-expression of Nanog and Cdx2 (arrows); in many cases, the Nanog-
expressing cells failed to form a well-defined inner cell mass (Fig. 3A, lower panels, Fig. 3B, right panels; SI 
Appendix, Fig. S5A). A fraction of Tet1/3 DKO embryos (6/16) had a relatively normal appearance (e.g. SI 
Appendix, Fig. S5B, left), but several of these showed variable coexpression of Nanog and Cdx2 (Fig. 5B, 
right). 
A similar failure of early lineage specification was observed at the peri-implantation blastocyst stage (E4.5). In 
control embryos, we observed well-developed layers of primitive ectoderm expressing Nanog, primitive 
endoderm expressing Gata6, and trophectoderm expressing Cdx2 (Fig. 3C, SI Appendix, Fig. S5C, top 
panels), whereas Tet1/3 DKO embryos showed strong dysregulation of these three lineage markers, with 
aberrant co-expression of the markers, poor separation of germ cell layers, and poor or failed development of 
primitive ectoderm and primitive endoderm as judged by Nanog and Gata6 staining (Fig. 3C, SI Appendix, 
Fig. S5C, bottom panels).  Again, some Tet1/3 DKO embryos (5/15) had a relatively normal appearance at 
E4.5, with high Nanog and Gata6 expression (SI Appendix, Fig. S5D), but most embryos showed variably 
delayed development as judged by size (Fig. 3C, SI Appendix, Fig. S5C and S5D; compare lengths of the 50 
mm scale bars in each panel).  Overall, there was marked phenotypic variability in Tet1/3 DKO embryos at 
each of the three stages profiled (E2.5, 3.5 and 4.5), and a steadily increasing fraction of abnormal embryos at 
later times. 
Increased transcriptome variability in Tet1/3 DKO blastocysts compared to controls 
To investigate the variable phenotypes of Tet1/3 DKO blastocysts at a molecular level, we performed RNA-
sequencing (RNA-seq) on single blastocysts (SI Appendix, Table S4).  At day 3.5 after timed-matings, we 
randomly chose and sequenced 3 control blastocysts from a litter of 7, and 5 Tet1/3 DKO blastocysts from a 
litter of 8 (again, the highly variable phenotypes of mutant embryos led us to sequence more mutant than 
control embryos). Despite low levels of Tet3 transcripts in control blastocysts, RNA-sequencing confirmed 
excision of the floxed Tet1 and Tet3 exons in Tet1/3 DKO blastocysts (SI Appendix, Fig. S6A, Dataset S1); 
Tet2 mRNA was expressed at considerably higher levels and showed no compensatory upregulation in Tet1/3 
DKO embryos relative to controls (SI Appendix, Fig. S6B). IDAX transcripts were not detected by RNA-seq 
(SI Appendix, Dataset S1), suggesting that Tet2 protein expression was unlikely to be controlled by IDAX (29) 
at this developmental stage.  Expression of Eif2s3y, Zfy1, Ddx3y, Usp9y and Uty on the Y chromosome and 
Xist on the X chromosome showed that the three control embryos were female whereas the Tet1/3 DKO group 
had 3 male and 2 female embryos (SI Appendix, Fig. S6C). The expression of imprinted genes in the Tet1/3 
DKO blastocysts was normal compared to controls.   
RNA sequencing revealed that Tet1/3 DKO blastocysts displayed considerably more transcriptome variability 
than the corresponding controls. Unsupervised clustering analysis based on similarities of the transcriptomes 
showed that control embryos clustered together whereas Tet1/3 DKO embryos formed two clusters (SI 
Appendix, Fig. S6D). The clustering was not influenced by the sex of the embryos: DKO 1 and 2 (male) 
clustered with the three control embryos (female), whereas the other three embryos (DKO 3, male; DKO 4 and 
5, female) formed a distinct group (SI Appendix, Fig. S6D).  Principal component analysis based on the 
expression profiles (with sex chromosome data removed) confirmed that control embryos clustered together 
whereas Tet1/3 DKO embryos showed a high degree of variance (Fig. 4A).  Emphasizing this variability, the 
number of genes differentially-expressed in each of the five Tet1/3 DKO blastocysts compared to the average 
of the 3 control blastocysts ranged from 172 differentially expressed genes in DKO2 to 1153 in DKO4 (adjusted 
p-value<0.05), with only 23 differentially expressed genes common to all 5 DKO blastocysts relative to controls 
(Fig. 4B).  
Even in the averaged transcriptomes of E3.5 blastocysts, the vast majority of expressed genes showed a much 
greater variability of expression in Tet1/3 DKO blastocysts relative to controls (Fig. 4C-4E; each gene is 
represented by a dot). As in 8-cell blastomeres, a correlation plot for the variance of gene expression showed 
that essentially all genes in the 5 DKO blastocysts were expressed more variably than in the 3 controls (Fig. 
4D), again in a manner independent of the level of gene expression (Fig. 4E). Consistent with our 
immunocytochemistry data, Nanog was one of the most variably expressed genes in DKO blastocysts 
compared to controls (Fig. 4C, 4F and 4G; SI Appendix, Dataset S1).  Other genes, such as Cdx2 and Oct4, 
showed less variability: Cdx2 mRNA expression was similar between the two groups (Fig. 4F, middle) whereas 
Oct4 mRNA expression showed a slight decrease in DKO embryos relative to control (Fig. 4F, bottom).  A 
heatmap comparing the expression of the top 1% of variable genes (n=178; indicated by red dots in Fig. 4C) in 
DKO embryos relative to controls showed that the most common pattern for the highly variable genes was 
expression comparable to controls in DKO embryos 1 and 2, versus poor expression relative to controls in 
DKO embryos 3, 4 and 5 (Fig. 4G). 
Together, these results show that in E3.5 blastocysts as well as in single blastomeres from 8-cell embryos, 
deletion of Tet1 and Tet3 results in a profound and global increase in the variability of gene expression.  We 
asked whether this variability was reflected in a corresponding global increase in the variability of DNA cytosine 
modification at different annotated regions of the genome (see section below).  
A few genes are reproducibly downregulated in Tet1/3 DKO blastocysts 
Comparing the group of five Tet1/3 DKO blastocysts to the group of three control blastocysts, and applying a 
an adjusted p-value of <0.01, we identified only 40 genes as consistently differentially expressed in DKO 
blastocysts compared to controls (SI Appendix, Dataset S1).  Among these 40 genes, the gene ranked at 
third place by p-value was Lifr, the receptor for the cytokine LIF (Fig. 4H, left; SI Appendix, Dataset S1). The 
active LIF receptor complex contains LIFR and its obligate binding partner, Gp130 (30), and Gp130 expression 
was also reproducibly low in Tet1/3 DKO blastocysts (Fig. 4H, right).  Mice deficient in LIFR subunits show 
variable phenotypes ranging from impaired implantation to perinatal lethality (31), potentially partly explaining 
the variable onset of embryonic lethality in Tet1/3 DKO embryos both before and after gastrulation. Embryonic 
stem cells (ESC) cannot be derived from Lifr-deficient blastocysts (31), and indeed we consistently failed to 
derive ESCs from Tet1/3 DKO blastocysts (18 embryos from 3 litters), despite successful establishment of 5 
different ESC lines from 11 control embryos. We also observed consistently reduced expression of several 
pluripotency-associated genes in Tet1/3 DKO embryos, including Tcl1 (T-cell leukemia-1, a gene involved in 
translocations to the TCR locus in T cell leukemias and also a target of Tet1 in ES cells (32)) (Fig. 4I, SI 
Appendix, Fig. S6E; Dataset S1). Sca1/2 expression was diminished in Tet1/3 DKOs embryos (SI Appendix, 
Fig. S6F), potentially explaining the hematopoietic defects observed in some embryos at later developmental 
stages (SI Appendix, Fig. S3F).  Genes involved in lipid and cholesterol biosynthesis were also reproducibly 
downregulated, as discussed below.  
Increased levels and variability of DNA modification in Tet1/3 DKO blastocysts compared to controls 
To investigate whether transcriptional variability reflected a corresponding variability in DNA modification 
status, we used targeted bisulfite sequencing to assess DNA cytosine modification at the Nanog locus, for 
which variable expression was strongly apparent both by immunocytochemistry and by RNA-seq. Because 
5mC is not distinguished from 5hmC, nor unmodified C from 5fC and 5caC, in bisulfite sequencing (33, 34), 
and because Tet2 expressed in Tet1/3 DKO embryos can generate oxi-mC, we use the term “DNA 
modification” in preference to “DNA methylation”, and specify the modified bases actually examined in each 
case.   
We first examined Nanog regulatory regions using bisulfite treatment followed by targeted PCR.  At the 8-cell 
stage, reduced representation bisulfite sequencing (RRBS) still shows evidence of widespread 5mC/5hmC 
(35). However we did not observe any substantial difference in the extent or variability of DNA modification at 
the Nanog promoter /transcription start site (TSS) or a distal (-5 kb) regulatory region (36) at either the E3.5 
blastocyst or the E2.5 8-cell stage (SI Appendix, Fig. S7A and S7B).  
To examine DNA modification more globally, we prepared and sequenced RRBS libraries from 3 control 
blastocysts (from a litter of 6), and 5 Tet1/3 DKO blastocysts (from a litter of 6, SI Appendix, Table S5). As 
expected, control blastocysts were substantially demethylated on all chromosomes (7-10% 5mC/5hmC; Fig 
5A). In contrast, the overall levels of 5mC/5hmC in the five different Tet1/3 DKO embryos were highly variable, 
with two blastocysts (DKOa, DKOb) resembling controls, and the three others showing variably increased 
levels of 5mC/5hmC (Fig 5A). Detailed analysis of DNA modification levels at specific genomic regions 
showed a substantial but variable increase in 5mC/5hmC at all genomic regions in Tet1/3 DKO embryos 
compared to controls (Fig. 5B), as shown for selected promoters and gene bodies in Figure 5C and SI 
Appendix, S7C.  We evaluated the variability of DNA modification (5mC/5hmC) at each CpG, eliminating 
CpG’s covered by < 8 reads as well as CpGs with < 10% 5mC+5hmC (Fig. 5D).  Tet1/3 DKO blastocysts 
displayed a much higher variability of DNA modification relative to controls, regardless of the actual level of 
modification present at each CpG.  
Together, our data indicate that loss of TET function results both in increased DNA modification as well as in 
increased variability of modification, consistent with the increased variability of gene expression observed in 
Figure 4. Because RNA-seq and RRBS DNA methylation analysis cannot currently be performed on the same 
blastocysts, a direct correlation of gene expression with DNA modification status is technically out of reach.   
Increased levels and variability of DNA modifications at repetitive elements in Tet1/3 DKO embryos 
correlates with altered and variable expression 
We examined 5mC/5hmC levels at repetitive elements in control and Tet1/3 DKO blastocysts. All elements – 
non-LTR (LINE, SINE) and LTR (LTR, IAP) retrotransposon groups, DNA transposons and satellite sequences 
– showed a variable increase in 5mC+5hmC in Tet1/3 DKO blastocysts compared to controls (Fig. 6A, top).  
To illustrate this point in more detail, the greater variability of DNA modification in LINE and LTR elements of 
Tet1/3 DKO blastocysts is shown at the level of individual CpGs in Figures 6B and 6C. In parallel, we 
assessed the expression levels of these repetitive elements using our single-embryo RNA-seq data (obtained 
from a different set of blastocysts for the reason outlined above). The expression of LTR and IAP elements 
was significantly downregulated in Tet1/3 DKO compared to control blastocysts (Fig. 6A, bottom); expression 
of LINEs and SINEs showed a decrease in mean expression levels as well as an increase in the variability of 
expression.  
Since single cells are technically not yet amenable to RRBS, we were unable to measure 5mC/5hmC in single 
blastomeres from control and Tet1/3 DKO 8-cell embryos.  Instead, we assessed the expression levels of 
retrotransposons, DNA transposons and satellite sequences at this stage (Fig. 6D). Confirming the results in 
blastocysts, expression of IAP elements was significantly downregulated in Tet1/3 DKO compared to control 8-
cell blastomeres whereas expression of SINES and LTRs was increased (Fig. 6D).   
Thus Tet1/3 DKO embryos show variably increased 5mC+5hmC as well as an increase in the variability of 
expression of transposable elements compared to control embryos, and may positively control IAP expression 
at the 8-cell and blastocyst stages of embryonic development.   
Deficiency of cholesterol synthesis in Tet1/3 DKO blastocysts results in failure of the sonic-hedgehog 
pathway in late embryogenesis 
Gene ontology (GO) analysis for the 40 genes consistently differentially regulated in Tet1/3 DKO embryos 
(adjusted p-value <0.01) identified a number of genes whose products regulate cellular lipid metabolism and 
cholesterol biosynthesis that were downregulated in Tet1/3 DKO embryos relative to controls (Fig. 7, SI 
Appendix, Fig. S8A and S8B; Dataset S1). The transcription factor Srebp2, encoded by the Srebf2 gene, 
regulates the expression of a large number of these enzymes; it is normally resident in the endoplasmic 
reticulum but is escorted to the Golgi by a chaperone, Scap, and then cleaved to release its DNA-binding 
domain when cells become depleted of cholesterol (37).  Four of the five Tet1/3 DKO embryos (DKO2-5) 
showed a strong reduction of Srebf2 mRNA expression; the fifth (DKO1) showed normal Srebf2 expression but 
strongly diminished expression of Scap mRNA (SI Appendix, Fig. S8C).  Using antibodies to N-terminal and 
C-terminal regions of Srebp2, which detect total (ER and nuclei) and ER-localised forms of Srebp2 respectively 
(37), we confirmed that Srebp2 protein expression was also significantly downregulated in Tet1/3 DKO 
embryos (SI Appendix, Fig. S8D and S8E). However, there was no change in the unmethylated (C/5fC/5caC) 
status of the Srebp2 TSS and promoter at early embryonic stages in Tet1/3 DKO embryos compared to 
controls (SI Appendix, Fig. S8F).  
Since sonic hedgehog (Shh) requires covalent modification by cholesterol for its activity (38), we speculated 
that defective cholesterol synthesis during the development of Tet1/3 DKO embryos might result in decreased 
functioning of the hedgehog-signaling pathway and contribute to developmental abnormalities.  Indeed, the 
phenotypes of late stage (E10.5) Tet1/3 DKO embryos – poor forebrain formation and abnormal facial 
structures (SI Appendix, Fig. S8G) – resembled the phenotypically heterogeneous holoprosencephaly with 
consistent forebrain defects and facial abnormalities observed in Shh deficiency as well as in mice with defects 
in cholesterol synthesis (39, 40).  Indeed mRNAs encoding signaling components (Patched1 (Ptch1), 
hedgehog interacting protein (Hhip)), transcription factors (Gli1/2, Pax1/9), and other targets (Cyclin D2 
(Ccnd2)) of the Hedgehog signaling pathway were significantly decreased in E10.5 Tet1/3 DKO embryos 
relative to controls (SI Appendix, Fig. S8H); these transcripts were not detectably expressed at either the 8-
cell or the blastocyst stage.  Consistent with neural defects, mRNAs encoding neural (Nestin, Sox1, Pax6) but 
not cardiac (Fgf10, Nkx2-5, TnnT2, Myh7) markers were also significantly reduced (SI Appendix, Fig. S8I and 
S8J).  
Dysregulation of imprinted gene expression at E10.5  
Even at this late stage, 5hmC levels were considerably lower in Tet1/3 DKO relative to control E10.5 embryos 
suggesting incomplete compensation from Tet2 (SI Appendix, Fig. S9A, left); however overall 5mC levels 
were not detectably affected in most embryos (SI Appendix, Fig. S9A, right), suggesting that any changes in 
DNA modification occurred at a locus-specific level.  We tested the DNA modification status of imprinted genes 
in genomic DNA of 4 control and 4 Tet1/3 DKO E10.5 embryos by BstUI digestion and qPCR quantification of 
methylated genomic DNA (41), after generating standard curves for amplification of short control and long 
differentially methylated regions (DMR)-containing amplicons (SI Appendix, Fig. S9B). Four different DMRs 
from 2 paternally and 2 maternally imprinted genes were analyzed for their level of DNA modification 
(5mC+5hmC) and for expression of the corresponding genes. Both maternally (Peg3 and Snrpn) and 
paternally (H19 and Igf2r) imprinted genes showed increased DNA modification at their DMRs and 
concomitantly decreased expression in E10.5 embryos (SI Appendix, Fig. S9C), suggesting that Tet1 and 
Tet3 regulate the expression and modification status of these imprinted genes during later embryonic 
development.  
 
Discussion   
Here we report the effects of TET loss-of-function in early embryogenesis.  With one exception (20), most 
previous work in this area has focused on loss of function of individual TET proteins (17, 19, 25, 42). Because 
TET proteins clearly function redundantly (20, 25, 43), we preferred to examine mice with a very substantial 
loss of TET function during early embryonic development.  We chose to delete both Tet1 and Tet3: Tet3 is 
present in zygotes and at the 2-cell stage whereas Tet1 is expressed from the 2-cell stage to the blastocyst.  
We find (as expected) that the effects of double deletion are considerably more striking than the effects of 
individual deletion of either Tet1 or Tet3.  More importantly, however, analysis of Tet1/3 DKO embryos 
revealed an unexpected phenotype of a global increase in transcriptional variability.   
Even in a population of genetically identical cells, individual cells exhibit a remarkable degree of diversity, most 
easily visualized through flow cytometric profiles of protein or reporter expression, which often span 1-2 orders 
of magnitude.  Variations in gene expression patterns within a single cell can be assessed by comparing the 
levels of two different reporter genes driven off the same promoter (intrinsic noise), whereas those that occur 
between cells (extrinsic noise) can be examined in many ways including single-cell RNA sequencing, the 
technique we have employed here (44-46). Cell-to-cell variability in gene expression reflects stochastic 
variation, differences in cell state or environmental input, and gene regulatory processes including the 
frequency and robustness of transcriptional initiation (46), the relative abundance of transcriptional regulators 
(47, 48), the size and frequency of transcriptional bursts (49), the spatial organization of the genome (50), and 
the relative efficiency of transcription versus translation (51) (reviewed in (45, 52)).  
Studies in yeast indicate that several epigenetic regulators can impose transcriptional consistency and 
suppress transcriptional noise. In many cases, this involves modulation of transcriptional elongation by RNA 
polymerase II (Pol II), a process linked to cotranscriptional histone modifications that regulate nucleosome 
disassembly and reassembly.  Eviction of acetylated nucleosomes ahead of Pol II permits efficient elongation, 
while reassembly of deacetylated nucleosomes behind the elongating polymerase prevents initiation at 
spurious sites. Consistent with this scenario, mutations in histone chaperones that promote nucleosome 
assembly/ disassembly, or in enzyme complexes that catalyze or erase histone modifications associated with 
gene bodies (e.g. H3K9/14 and H4 acetylation, H2B ubiquitylation, H3K36 di- and tri-methylation), affect 
transcriptional consistency in yeast (49, 53-55). 
Our data suggest that in mammals, TET-mediated DNA modifications may play a similar role.  In support of 
this hypothesis, 5hmC is present at the highest levels in gene bodies of the most highly expressed genes (43, 
56-60), and TET proteins have been linked to many processes and histone modifications associated with 
transcriptional variability. (i) In yeast, the Set2 methyltransferase complex travels with RNA pol II and 
methylates H3K36 in gene bodies; the H3K36me3 modification is recognized by the Sin3a/Rpd3 histone 
deacetylase (HDAC) complex, which permits nucleosome reassembly by deacetylating lysines on histones 3 
and 4, thus preventing spurious initiation at intragenic sites (53).  In mammalian cells, TET functions are linked 
to both types of histone modifications: high levels of 5hmC are present in the gene bodies of expressed genes; 
5hmC distribution in gene bodies is strongly correlated with that of H3K36me3 (43, 56-60); and TET1 co-
immunoprecipitates with SIN3A and HDAC1/2 in mouse ES cells (61). (ii) Also in yeast, H2B ubiquitylation has 
been implicated in nucleosome dynamics (54, 55), and a screen for chromatin regulators that altered the 
variability of reporter expression in yeast showed that H2B ubiquitylation recruited the Set3C HDAC complex, 
thereby limiting the high rate of Pol II elongation associated with transcriptional bursts (49). Similarly in 
mammalian cells, TET2 and TET3 have been linked to H2B-ubiquitination through their association with the 
enzyme O-GlcNAc transferase (OGT) (62-64); OGT attaches O-linked N-acetylglucosamine to H2B (63), a 
modification required for subsequent H2B ubiquitylation (65). (iii) Finally, the linear extent (“breadth”) of 
H3K4me3 enrichment around gene promoters has been correlated with transcriptional elongation, Pol II 
pausing/ processivity, increased DNase I accessibility and increased transcriptional consistency in mammalian 
cells (66); the TET proteins TET2 and TET3 are implicated in this process because of their association with the 
SET/COMPASS complex, which contains the SETD1A lysine methyltransferase that deposits H3K4me3 (64).   
In a recent elegant study, interference with one of two redundant pathways of gene regulation was shown to 
result in variable penetrance of an organismal phenotype, ultimately stemming from increased transcriptional 
noise (48).  In C. elegans, end-1 and end-3 both control the expression of elt-2, a transcriptional regulator 
required for specification of the "E” cell, a precursor cell required for intestinal development. Mutations in 
upstream regulators (skn-1, med-1/2) that caused decreased expression of end-3 transcripts were also 
associated with an increased variability of end-1 expression, resulting in the emergence of a threshold effect 
that decreased elt2 expression and led to incomplete penetrance of the final phenotype, the total number of 
intestinal cells and formation of a normal intestine.  Although TET enzymes are likely to be ubiquitous global 
regulators that affect the expression of many genes in mammalian cells, the parallels are clear – double 
deficiency of Tet1 and Tet3, through strong interference with TET function and pronounced alterations in DNA 
cytosine modification, may not so much interfere with gene expression per se, as impose a global phenotype of 
increased transcriptional variability.  
It seems self-evident that in a given cell type, transcriptional variability would affect certain gene networks more 
than others. Indeed, Tet1/3 DKO blastocysts showed reproducible downregulation of a core set of genes 
involved in cholesterol biosynthesis and in Hedgehog signaling.  Similarly, Tet1-deficient ES cells show clear 
skewing towards the trophectoderm lineage, both in cell culture and in teratomas (67), and Tet2-deficient 
haematopoietic stem/precursor cells show skewed differentiation towards the myeloid lineage (19, 68). If TET 
proteins maintain the consistency of gene transcription during cell lineage specification as suggested here, 
their loss might be expected to disturb preferentially the expression of gene products – including critical 
transcription factors and proteins in key signalling pathways – involved in determining cell fate.  
Whether TET loss-of-function acts through increased DNA methylation, loss of oxi-mC production or both 
remains unclear.  The genome-wide DNA demethylation observed in early embryos appears to be a default 
pathway independent of TET function or oxi-mC modification: both the 5hmC-modified paternal genome and 
the unmodified maternal genome are passively demethylated at similar rates during the robust cell divisions 
that occur in the early embryo (69). Even in zygotes, demethylation of both maternal and paternal pronuclei 
requires DNA replication, a process only partially dependent on Tet3 (14, 15). For each observed outcome, the 
relative contributions of oxi-mC production and DNA demethylation may be distinguished by comparing cells 
deficient in DNA methyltransferases, which would be depleted for both 5mC and oxi-mC, with cells deficient in 
TET proteins, which lack only oxi-mC. Specific downstream mechanisms include altered recruitment of key 
transcription factors to their binding sites in DNA, either through direct modification of the binding sequences, 
modulation of chromatin accessibility, or both; retrotransposon modification and expression, since insertion of 
these elements is known to create alternative promoters for host genes during early embryogenesis (70, 71); 
changes in local histone modifications, as suggested by an early study in which DNA methylation in the gene 
body was shown to regulate Pol II elongation efficiency through H3K4-di/tri methylation and H3K9/14-
acetylation (72). Future studies will clarify these points.  
 
 
Materials and Methods 
Generation of Tet1- and Tet3- deficient mice  
The endogenous Tet1 locus was targeted for conditional Tet1 and Tet3 alleles were generated by excision of 
exons 8, 9, and 10 (Fig. S1A, top) and exon 2 respectively (Fig. S1B). 
Single- embryo and cell RNA sequencing 
CTL and Tet1/3 DKO 8-cell embryos and blastocysts were collected at E2.5 and E3.5 respectively. 8-cell 
embryos were dissociated, lysed and converted into double stranded cDNA using SMARTer ultra low RNA kit 
for Illumina sequencing (Clontech). 1 ng of cDNA for each sample was used for preparing libraries using 
Nextera XT DNA sample preparation kit (IIlumina) and sequenced using an Illumina HISEQ 2500 instrument. 
RNA-seq data was mapped against mm9 using Tophat. Sequencing read counts per gene were calculated 
using htseq-count.  
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Figure Legends  
Figure 1. Analyses of control and Tet1/3 DKO 2-cell and 8-cell embryos. (A) Bar graph showing the 
percentage of 1-cell, 2-cell, 4-cell and 8-cell embryos in control (CTL) and Tet1/3 DKO embryos harvested at 
E2.5. Almost all CTL embryos have reached the 8-cell stage whereas a substantial fraction of Tet1/3 DKO 
embryos show aborted or delayed development. (B) Apoptosis (left), nuclear fragmentation (middle) and 
mitotic defects (right) in representative non-viable 2-cell embryos from Tet1/3 DKO mice revealed by DAPI 
staining. (C) Immunocytochemistry for the lineage markers Nanog and Cdx2 does not reveal any pronounced 
differences between CTL and Tet1/3 DKO 8-cell embryos. Cdx2 was expressed in all blastomeres whereas 
Nanog expression was typically not detected in 8-cell embryos (or occasionally detected in one or a very few 
blastomeres). (D) Immunocytochemistry using antibodies to 5mC and 5hmC shows global loss of 5hmC and 
concomitant increase of 5mC in nuclei of Tet1/3 DKO 8-cell embryos compared to CTL. Scale bar 50 mm. (E) 
Top, Merged and enlarged images of a second control embryo; bottom, Tet1/3 DKO embryo from Figure 1d 
middle, stained with antibodies to 5mC and 5hmC.  
Figure 2. Transcriptional variability associated with Tet1/3 deficiency revealed by single-cell RNA sequencing 
of individual blastomeres from 8-cell embryos. (A) Principal component analysis of the transcriptomes of 10 
CTL and 35 Tet1/3 DKO with the sex chromosome information removed, showing that the 35 Tet1/3 DKO 
blastomeres are more widely separated than the 10 CTL blastomeres for both principal component (PC) 1 
(absolute gap, 37 vs. 8) and PC2 (17 vs. 13). Groups A-D identified by the clustering analysis of Figure 2A are 
indicated. (B) The box-and-whisker plot depicts the distribution of stabilized variances (gene expression 
variances across samples independent of their expression strength (see Methods)) in 8-cell embryos. Median 
variances are shown at the bottom. Upper and lower whiskers represent >75% and <25%, respectively. (C) 
Correlation plot of expression variances of all genes expressed in single cells of CTL and Tet1/3 DKO 8-cell 
embryos. Each gene is represented by a dot. Most genes fall above the diagonal, indicating greater variability 
of expression in Tet1/3 DKO blastomeres compared to controls. (D) The ratios of gene expression variance 
between CTL and Tet1/3 DKO blastomeres are plotted against the average expression level for each gene.  
The increased gene expression variance observed in blastomeres from Tet1/3 DKO 8-cell embryos is 
independent of the level of gene expression. (E) The genes expressed with highest variance in CTL and Tet1/3 
DKO blastomeres, Zfp820 (left panel) and Zbed3 (right panel) respectively, and a gene that shows low 
variance in both samples, Invs (bottom panel), are indicated (also see Fig S4E). (F) Principal component 
analysis of the combined RNA-seq data from our study and the single-cell analysis of zygotes, 2-cell and 4-cell 
embryos performed by Biase et al. (2014).  
Figure 3. Expression of the lineage markers Nanog, Cdx2 and Gata6 in control and Tet1/3 DKO E3.5 and E4.5 
embryos. (A) Immunocytochemistry for Nanog and Cdx2 expression shows dysregulation of the first step of 
lineage commitment in Tet1/3 DKO E3.5 embryos compared to control (CTL).  Arrows indicate aberrant co-
expression of Nanog and Cdx2. (B) Two more control blastocysts (left panel) and three Tet1/3 DKO 
blastocysts with poor or failed Nanog expression (right panel). (C) Immunocytochemistry for Nanog, Cdx2 and 
Gata6 expression shows dysregulation of the second step of lineage commitment in Tet1/3 DKO E4.5 
embryos.  Scale bar 50 mm.  Listed in red are the numbers of embryos displaying the indicated normal or 
abnormal phenotype, out of the total number of embryos examined.  For more examples see Figure S5.  
Figure 4. Transcriptional variability associated with Tet1/3 deficiency revealed by RNA sequencing of single 
E3.5 blastocysts. (A) Principal component analysis (PCA) of three CTL and five Tet1/3 DKO transcriptomes 
with the sex chromosome information removed, showing that the three control blastocysts cluster together 
whereas the five Tet1/3 DKO blastocysts are widely separated. (B) Numbers of genes differentially expressed 
in each of the Tet1/3 DKO blastocysts compared to the average of the CTL blastocysts. Only 23 genes are 
differentially expressed in all 5 Tet1/3 DKO blastocysts relative to control blastocysts. (C) Overall increase in 
the variance of gene expression in Tet1/3 DKO compared to CTL blastocysts. Each gene is represented by a 
dot, with Nanog indicated in green. Genes shown in red are those with highest (top 1%, n=178) vsd variance in 
Tet1/3 DKO blastocysts. (D) Correlation plot of expression variances of all genes from CTL and Tet1/3 DKO 
embryos. Most genes fall above the diagonal, indicating greater variability of expression in Tet1/3 DKO 
blastocysts compared to controls. (E) The ratios of gene expression variance between CTL and Tet1/3 DKO 
blastocysts are plotted against the average expression level for each gene. The increased gene expression 
variance observed in Tet1/3 DKO blastocysts is independent of the level of gene expression. (F) Nanog, Cdx2 
and Oct4 mRNA expression in control (CTL) and Tet1/3 DKO E3.5 blastocysts quantified by RNA-seq. (G) 
Heatmap showing expression of the top 1% of variable genes in Tet1/3 DKO blastocysts compared to controls. 
Nanog is indicated by an arrow. (H) Lifr, Gp130 and (I) Tcl1 expression levels in control (CTL) and Tet1/3 DKO 
blastocysts assessed by RNA-seq (**adjusted p-value<0.01).  
Figure 5.  The variable levels of DNA modification (5mC+5hmC) in Tet1/3 DKO E3.5 blastocysts parallel the 
transcriptional variability observed above. (A) Modification levels on each chromosome were plotted for 3 CTL 
and 5 Tet1/3 DKO E3.5 embryos based on RRBS analysis. Note that the DKOa blastocyst is the only one with 
a Y chromosome and that cytosines in control unmodified lambda DNA show more than 98% conversion to T 
in all embryos. (B) The levels of DNA modification at CpG islands (CGI), transcription factor binding sites 
(TFBS), enhancers, DNaseI accessible regions, promoter (±2 kb relative to the TSS), gene bodies (subdivided 
into 5’UTR, exon, intron, 3’UTR) and intergenic regions.  Each circle represents one blastocyst, with the 
embryo ID shown within each circle: blue circles, control blastocysts a-c; red circles, Tet1/3 DKO blastocysts a-
e. (C) Modification levels of part of the gene body of Sfi1 and the entire gene body of Prdm16 from individual 
control and Tet1/3 DKO blastocysts.  Each bar represents one CpG, and the full length of each bar represents 
100% modification (red, 5mC+5hmC; blue, C+5fC+5CaC). (D) The correlation plot depicts variances in the 
DNA modification level of individual CpGs from CTL and Tet1/3 DKO embryos. Each dot represents one CpG 
(>8 reads and >10% 5mC+5hmC). The level of DNA modification at each CpG is graded from blue to red. Most 
dots fall above the diagonal regardless of modification level, indicating thatTet1/3 DKO blastocysts show 
greater variability of DNA modification compared to controls.  
Figure 6. Variability of DNA modification and expression of repetitive elements in Tet1/3 DKO early embryos. 
(A) Top, DNA modification (5mC+5hmC) levels associated with LINE, SINE, LTR, IAP, DNA transposon and 
satellite sequences taken from RRBS data. Blue circles, control blastocysts; red circles, Tet1/3 DKO 
blastocysts.  Bottom, expression levels of the corresponding elements taken from RNA-seq data using a 
separate set of blastocysts. Blue circles, control blastocysts; red circles, Tet1/3 DKO blastocysts (see Fig. 3).  
(B, C) The variance ratios of DNA modification for individual CpGs within LINEs (B) and LTRs (C) of CTL and 
Tet1/3 DKO embryos are plotted against average DNA modification level (top) and RRBS coverage (bottom). 
FC, fold change. (D) Expression of LINE, SINE, LTR, IAP, DNA transposon and satellite sequences taken from 
RNA-seq data on 10 individual CTL and 35 individual Tet1/3 DKO blastomeres from 8-cell embryos. Note the 
strongly diminished expression of IAP elements, also observed for E3.5 blastocysts in Figure 6A.  
Figure 7. The reproducible downregulation of genes in the cholesterol biosynthetic pathway in Tet1/3 DKO 
E3.5 embryos compared to controls is associated with a phenotype that resembles that of sonic hedgehog 
deficiency. Shown is the sequence of enzymes in the cholesterol biosynthesis pathway, indicating the degree 
of impaired expression based on RNA-seq data. The averaged normalized counts of three control and five 
Tet1/3 DKO embryos are plotted. Adjusted p-values are shown at right.  
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